Charles River Laboratories Stock Outlook: Is Wall Street Bullish or Bearish?

Wilmington, Massachusetts-based Charles River Laboratories International, Inc. (CRL) is a leading provider of preclinical and clinical laboratory services for the pharmaceutical, biotechnology, and medical device industries. The company, with a market cap of $8.7 billion, operates globally, offering services such as animal models for research, toxicology studies, microbial testing, and biologics manufacturing support. 

CRL shares have significantly underperformed the broader market over the past year. CRL has dropped 32.5% over this time frame, while the broader S&P 500 Index ($SPX) has rallied 17%. Moreover, on a YTD basis, the stock is down 9.5%, compared to SPX’s 1.3% gains.